Bioprox Healthcare has developed unique, exclusive expertise in producing probiotics at very high concentrations with optimized stability.
Cutting-edge technical expertise and quality driven by skilled human resources:
—
Experienced team of doctors, engineers and technicians in development, production and optimization.
—
A QA & QC team for quality support (analysis methods on petri dishes, cytofluorometry).
–
Partnerships with scientific network
(INRAe, CNRS, Pasteur Institute…)
Advanced technologies
and tools
–
Molecular biology laboratory utilizing state-of-the-art software and techniques
–
Access to databases for enhanced strain identification, phenotype/genotype correlation
–
Application of advanced techniques to verify strain purity
Research and testing
under real-world conditions
–
In-depth understanding of the behaviour of our probiotic strain catalogue
• genetic identification
• virulence factors
• survival in gastrointestinal conditions
• probiotic mechanisms and functions for health benefits
• stability
–
Development studies
for your proprietary next-generation strains
Processes that match your needs
—
Optimization of fermentation parameters
—
Customized analysis
—
Strain/matrix screening
—
Production and storage stability optimization
Our R&D department, with its teams of engineers and state-of-the-art equipment, develops manufacturing processes designed to achieve maximum yields at an industrial scale. Associated with our 40 years of experience in industrial fermentation, these processes guarantee batch-to-batch repeatability and consistent quality in our cultures.
Interested?
Collaborations with the most demanding clients and partnerships with academic experts in freeze-drying, combined with ongoing technological and scientific monitoring, have driven Bioprox Healthcare to pursue the highest stability standards for its lyophilized probiotic powders.
We have the capability to identify, at the lab level, the most effective processes and technologies for industrial-scale production. Our R&D and manufacturing teams work closely together to transition your strains from cryotubes to the first industrial batch within just 4–6 months.
Find solutions or need support?
S.svg){kind=logo}